Pancreatic Cancer Research

ResearcherAsan Medical CenterNo recent work listed

Ji Hun Kang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-4213-9428; OpenAlex author ID A5101571580. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
12
Papers, trials and grants by year

2021: 2 papers

Papers 2

  1. Multiparametric MRI for prediction of treatment response to neoadjuvant FOLFIRINOX therapy in borderline resectable or locally advanced pancreatic cancer. Co-author DOI 10.1007/s00330-020-07134-8↗
  2. CT-determined resectability of borderline resectable and unresectable pancreatic adenocarcinoma following FOLFIRINOX therapy. Co-author DOI 10.1007/s00330-020-07188-8↗

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jin Hee Kim · 2 shared papers, 2021 · strength 0.25
  2. Kyu‐pyo Kim · 2 shared papers, 2021 · strength 0.25
  3. Seung Soo Lee · 2 shared papers, 2021 · strength 0.25
  4. Jae Ho Byun · 2 shared papers, 2021 · strength 0.25
  5. Hyoung Jung Kim · 2 shared papers, 2021 · strength 0.25
  6. Changhoon Yoo · 2 shared papers, 2021 · strength 0.25
  7. Song Cheol Kim · 2 shared papers, 2021 · strength 0.25
  8. Baek‐Yeol Ryoo · 1 shared paper, 2021 · strength 0.13
  9. Moon-Gyu Lee · 1 shared paper, 2021 · strength 0.12
  10. Jong Keon Jang · 1 shared paper, 2021 · strength 0.12
  11. Seung‐Mo Hong · 1 shared paper, 2021 · strength 0.12
  12. Dong‐Wan Seo · 1 shared paper, 2021 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.